Healthy Aging Among Trans People Using Hormone Therapy: Setting the Research Agenda
-
Year 2024
- Principal investigator Devon Greyson
- Co-lead(s) Jerilynn Prior, UBC
- Host institution University of British Columbia
- Research location University of British Columbia - Vancouver Campus
-
Team members
- A.J. Lowik, University of British Columbia
- Jerilynn Prior, University of British Columbia
- Maria Mulder, University of British Columbia
- Lauren M L Galbraith, West Kootenay Family Planning
- Molly R. Altman, University of Washington
- Fin Gareau, Trans Specialty Care
- Everett Blackwell, Everett Blackwell Consulting
- Nicola Hare, ANKORS Trans Connect
- Zed Payne, Big Bros Barbershop
- Lucas Wilson, TransCare BC
Although trans people have always existed, with improved clinical care, growing numbers of trans people who have accessed gender-affirming hormone therapy (GAHT) are reaching middle age and beyond. We know little about what to expect or how to optimize health for midlife trans people using GAHT. Better understanding the science of these midlife health experiences can reduce disparities faced by trans people, and possibly offer insights to improve well-being of cisgender people experiencing troubling midlife hormonal symptoms.
This proposed project will be a 1-year process of convening researchers, trainees, and knowledge users to collaboratively develop an agenda for research priorities, methods, language, and other key elements of science into the well-being of aging trans individuals using GAHT.
This 1-year project has 6 steps:
1. The Core Team will draft discussion guide.
2. Expert Advisory Committee will meet and develop draft research priorities.
3. Broader Community Survey will elicit feedback on draft priorities.
4. Core Team will analyze survey and revise research priorities.
5. Expert Advisory Committee will review and refine this revision.
6. We will share findings with the community, clinicians, and researchers.